Schroer: Biotech Will Turn Around By: Benzinga via Benzinga February 13, 2016 at 22:12 PM EST The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) has lost more than 26.5 percent since the beginning of the year. Allianz ... Read More >> Related Stocks: Alexion Pharmaceuticals Biogen Idec Bristol-Myers Squibb Celgene Corp Gilead Sciences Nasdaq Biotechnology Ishares ETF Pfizer UnitedHealth Group Vertex Pharmaceuticals